Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Morphine and Sufentanil for Post-VATS Analgesia
NCT02152514Phase 4Terminated
- Sponsor
- Université de Sherbrooke
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of morphine and sufentanil in postoperative pain, sponsored by Université de Sherbrooke. Primary endpoint: Hydromorphone consumption at 24 hours. Started Apr 2013; status: terminated.
02
Drugs
morphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02152514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152514.